v3.26.1
Stockholders' Equity
6 Months Ended
Jun. 28, 2026
Stockholders' Equity Note [Abstract]  
Stockholders' Equity

Note 10. Stockholders’ Equity

Stock Repurchases

From time to time, the Company’s Board of Directors has authorized programs under which the Company may repurchase shares of its common stock, depending on market conditions, in the open market or through privately negotiated transactions. Under the authorizations, the timing and actual number of shares subject to repurchase are at the discretion of management and are contingent on a number of factors, such as levels of cash generation from operations, cash requirements for acquisitions and the price of the Company’s common stock. During the six months ended June 28, 2026 and June 29, 2025, the Company repurchased, retired and reported, based on trade date, approximately 1.5 million and 0.5 million shares of common stock, at a cost of approximately $32.9 million and $15.0 million, respectively. On April 22, 2026, the Company’s Board of Directors authorized an incremental $75.0 million for repurchases of the Company’s common stock under the existing repurchase program. As of June 28, 2026, approximately $75.0 million remained authorized for repurchase under the repurchase program.

The Company’s policy related to repurchases of its common stock is to charge the excess of cost over par value to retained earnings. All repurchases were made in compliance with Rule 10b-18 under the Securities Exchange Act of 1934, as amended.

 

Restricted Stock Unit Withholdings

The Company withholds shares of its common stock to facilitate the administrative process of withholding and remitting personal income and payroll taxes for individuals receiving RSUs. The Company withheld and reported, based on trade date, approximately 376,000 shares and 370,000 shares of common stock, at a cost of approximately $8.6 million and $9.7 million, during the six months ended June 28, 2026 and June 29, 2025, respectively.

Accumulated Other Comprehensive Income (Loss)

The following tables set forth the changes in accumulated other comprehensive income (loss) (“AOCI”) by component:

 

(In thousands)

 

 

Unrealized gains (losses)
on available
-for-sale
investments

 

 

 

Unrealized
gains (losses)
on derivatives

 

 

 

Estimated tax benefit (provision)

 

 

 

Total

 

 

 

 

(In thousands)

 

Balance as of December 31, 2025

 

 

$

160

 

 

 

$

39

 

 

 

$

(3

)

 

 

$

196

 

Other comprehensive income (loss) before reclassifications

 

 

 

(244

)

 

 

 

(131

)

 

 

 

32

 

 

 

 

(343

)

Less: Amount reclassified from accumulated other comprehensive income (loss)

 

 

 

 

 

 

 

(146

)

 

 

 

31

 

 

 

 

(115

)

Net current period other comprehensive income (loss)

 

 

 

(244

)

 

 

 

15

 

 

 

 

1

 

 

 

 

(228

)

Balance as of June 28, 2026

 

 

$

(84

)

 

 

$

54

 

 

 

$

(2

)

 

 

$

(32

)

 

(In thousands)

 

 

Unrealized gains (losses)
on available
-for-sale
investments

 

 

 

Unrealized
gains (losses)
on derivatives

 

 

 

Estimated tax
benefit (provision)

 

 

 

Total

 

Balance as of December 31, 2024

 

 

$

169

 

 

 

$

79

 

 

 

$

(7

)

 

 

$

241

 

Other comprehensive income (loss) before reclassifications

 

 

 

(134

)

 

 

 

(985

)

 

 

 

196

 

 

 

 

(923

)

Less: Amount reclassified from accumulated other comprehensive income (loss)

 

 

 

 

 

 

 

(820

)

 

 

 

172

 

 

 

 

(648

)

Net current period other comprehensive income (loss)

 

 

 

(134

)

 

 

 

(165

)

 

 

 

24

 

 

 

 

(275

)

Balance as of June 29, 2025

 

 

$

35

 

 

 

$

(86

)

 

 

$

17

 

 

 

$

(34

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

The following table provides details about significant amounts reclassified out of each component of AOCI:

 

 

 

 

Three Months Ended

 

 

 

Six Months Ended

 

(In thousands)

 

 

June 28, 2026

 

 

 

June 29, 2025

 

 

 

June 28, 2026

 

 

 

June 29, 2025

 

Amount Reclassified from AOCI

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Gains (losses) on cash flow hedge:

 

Foreign currency forward contracts

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Affected line item in the statement of operations

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net revenue

 

$

 

(95

)

 

$

 

(542

)

 

$

 

(225

)

 

$

 

(1,064

)

Cost of revenue

 

 

 

1

 

 

 

 

3

 

 

 

 

2

 

 

 

 

3

 

Research and development

 

 

 

 

 

 

 

20

 

 

 

 

14

 

 

 

 

52

 

Sales and marketing

 

 

 

22

 

 

 

 

71

 

 

 

 

46

 

 

 

 

150

 

General and administrative

 

 

 

6

 

 

 

 

10

 

 

 

 

17

 

 

 

 

39

 

Total before tax

 

 

 

(66

)

 

 

 

(438

)

 

 

 

(146

)

 

 

 

(820

)

Tax impact

 

 

 

14

 

 

 

 

92

 

 

 

 

31

 

 

 

 

172

 

Total, net of tax

 

$

 

(52

)

 

$

 

(346

)

 

$

 

(115

)

 

$

 

(648

)